Goodman Financial’s AbbVie ABBV Stock Holding History

Goodman Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-700	Closed	-$68K	–	54
2017 Q4	$68K	Buy	+700	New	+$66K	0.03%	79

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goodman Financial's ABBV Position: Q1 2018 in Review

Goodman Financial sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 700 shares — an estimated $68K sold.

Goodman Financial first reported a position in ABBV in Q4 2017 and held it in 1 quarter. The position peaked at $68K in Q4 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Goodman Financial reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Goodman Financial sold 700 AbbVie shares in Q1 2018, an estimated $68K.
Goodman Financial first reported a position in AbbVie in Q4 2017 and held it in 1 quarter.
Goodman Financial's AbbVie position peaked at $68K in Q4 2017.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Goodman Financial's 13F filing for Q1 2018, filed 7 May 2018.